Archives des Oncology - Cegedim Health Data

Digoxin use is associated with pancreatic cancer risk but does not affect survival

Boursi B, Huber JS, Haynes K, Mamtani R & Yang Y

Cancer Causes & Control 2021 10.1007/s10552-020-01352-7

Lire la publication

Angiotensin converting enzyme inhibitors and the risk of hepatocellular cancer: a nested cohort analysis

Menon S & Mathew R

Hepathology Oncology

Gut 2021 10.1136/gutjnl-2020-bsgcampus.278

Lire la publication

A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes

Boursi B, Finkelman B, Giantonio BJ, Haynes K, Rustgi AK, Rhim AD, Mamtani R & Yang YX

Endocrinology Oncology

European Journal of Gastroenterology & Hepatology 2021 10.1097/MEG.0000000000002052

Lire la publication

Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results

Lai J, Mak V, Bright CJ, Lyratzopoulos G, Elliss‐Brookes L & Gildea C

Oncology

International Journal of Cancer 2021 10.1002/ijc.33277

Lire la publication

Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases

George G, Garmo H, Scailteux L, Balusson F, De Coster G, De Schutter H, Kuiper JG, Oger E, Verbeeck J & Van Hemelrijck M

Cardiovascular diseases Oncology PharmacoEpidemiology

International Journal of Cancer 2021 10.1002/ijc.33397

Lire la publication

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer

Liu J, Shen C, Lau WCY, Shao S, Man KKC, Hsu R, Wu C & Lai EC

Neurology Oncology PharmacoEpidemiology Urology

Cancers 2021 10.3390/cancers13153861

Lire la publication

Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study

Herbert A, Rafiq M, Pham TM, Renzi C, Abel GA, Price S, Hamilton W, Petersen I & Lyratzopoulos G

Gastroloenterology Oncology

PLoS Medicine 2021 10.1371/journal.pmed.1003708

Lire la publication

Validity of diagnostic codes for identifying cutaneous squamous cell carcinoma in The Health Improvement Network

Z.C. Chiesa Fuxench, A.B. Troxel, J.M. Gelfand

Oncology

British Journal of Dermatology 2017 10.1111/bjd.14957

Lire la publication

Effects of chronic exposure of hydroxychloroquine/chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseases.

Fardet L, Nazareth I, Petersen I

Oncology PharmacoEpidemiology

Clinical Epidemiology 2017 10.2147/CLEP.S143563

Lire la publication

Living With an Older Person Dying From Cancer, Lung Disease, or Dementia: Health Outcomes From a General Practice Cohort Study.

Sampson EL, Lodwick R, Rait G, Candy B, Low J, King M, Petersen I

Demographic Neurology Oncology Respiratory

Journal of Pain and Symptom Management 2016 10.1016/j.painsymman.2015.12.319

Lire la publication

Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom.

Lucía Cea Soriano, Montse Soriano-Gabarró, Luis A García Rodríguez

Oncology

Pharmacoepidemiology and Drug Safety 2016 25(4):385-91

Lire la publication

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett’s oesophagus: a population- based case-control study

Masclee GM, Coloma PM, Spaander MC, Kuipers EJ & Sturkenboom MC

Oncology

BMJ Open 2015 29;5(1):e006640

Lire la publication

Nos publications

Les publications : Oncology

Digoxin use is associated with pancreatic cancer risk but does not affect survival

Boursi B, Huber JS, Haynes K, Mamtani R & Yang Y

Angiotensin converting enzyme inhibitors and the risk of hepatocellular cancer: a nested cohort analysis

Menon S & Mathew R

A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes

Boursi B, Finkelman B, Giantonio BJ, Haynes K, Rustgi AK, Rhim AD, Mamtani R & Yang YX

Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results

Lai J, Mak V, Bright CJ, Lyratzopoulos G, Elliss‐Brookes L & Gildea C

Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases

George G, Garmo H, Scailteux L, Balusson F, De Coster G, De Schutter H, Kuiper JG, Oger E, Verbeeck J & Van Hemelrijck M

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer

Liu J, Shen C, Lau WCY, Shao S, Man KKC, Hsu R, Wu C & Lai EC

Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study

Herbert A, Rafiq M, Pham TM, Renzi C, Abel GA, Price S, Hamilton W, Petersen I & Lyratzopoulos G

Validity of diagnostic codes for identifying cutaneous squamous cell carcinoma in The Health Improvement Network

Z.C. Chiesa Fuxench, A.B. Troxel, J.M. Gelfand

Effects of chronic exposure of hydroxychloroquine/chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseases.

Fardet L, Nazareth I, Petersen I

Living With an Older Person Dying From Cancer, Lung Disease, or Dementia: Health Outcomes From a General Practice Cohort Study.

Sampson EL, Lodwick R, Rait G, Candy B, Low J, King M, Petersen I

Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom.

Lucía Cea Soriano, Montse Soriano-Gabarró, Luis A García Rodríguez

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett’s oesophagus: a population- based case-control study

Masclee GM, Coloma PM, Spaander MC, Kuipers EJ & Sturkenboom MC